Related references
Note: Only part of the references are listed.The Relationship Between the Level of Serum ESM-1 and Lp-PLA2 in Patients With Acute ST-Segment Elevation Myocardial Infarction
Peng Wei et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Comparison of serum Lp-PLA2 levels in ischemic stroke patients with H-type hypertension or non-H-type hypertension
Jie Qiao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy
Biao Huang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Serum lipoprotein-associated phospholipase A2 as a promising prognostic biomarker in association with 90-day outcome of acute intracerebral hemorrhage
Lin Bian et al.
CLINICA CHIMICA ACTA (2019)
Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor
Biao Huang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells
Laura Lehtinen et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Advantages of the lipoprotein-associated phospholipase A2 activity assay
Leslie J. Donato et al.
CLINICAL BIOCHEMISTRY (2016)
Clinical Diagnosis and Management of Breast Cancer
Elizabeth S. McDonald et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Xiaofeng Dai et al.
JOURNAL OF CANCER (2016)
Ki-67 as a prognostic marker according to breast cancer molecular subtype
Nahed A. Soliman et al.
CANCER BIOLOGY & MEDICINE (2016)
Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
Constantinos C. Tellis et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
Paula Vainio et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype
Helene R. McMurray et al.
NATURE (2008)
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress
Wolfgang Koenig et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Ultrasensitive detection of pepsinogen I and pepsinogen II by a time-resolved fluoroimmunoassay and its preliminary clinical applications
B Huang et al.
ANALYTICA CHIMICA ACTA (2006)
Serum lipid alterations in acute lymphoblastic leukemia of childhood
M Moschovi et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.
CJ Packard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)